You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atypical chronic myeloid leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Geriatric assessment (GA) pre-transplant
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 24, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Neutrophilic Leukemia
  • Laboratory Biomarker Analysis
  • +3 more
  • Palo Alto, California
  • +6 more
Oct 22, 2020

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

      Recruiting
      • Myelofibrosis
      • +2 more
      • Charlottesville, Virginia
        Danyelle Coley
      Jan 18, 2023

      MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Subcutaneous azacitidine
      • Oral decitabine/cedazuridine
      • Newcastle, New South Wales, Australia
        Calvary Mater Newcastle
      May 29, 2023

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      Chronic Myeloid Leukemia (CML) Trial in France

      Recruiting
      • Chronic Myeloid Leukemia (CML)
        • Annecy, France
        • +11 more
        Jul 18, 2023

        Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

        Not yet recruiting
        • Myelodysplastic Syndrome
        • +4 more
        • UAE Inhibitor TAK-243
        • (no location specified)
        Oct 20, 2022

        Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

        Recruiting
        • Acute Biphenotypic Leukemia
        • +13 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 19, 2023

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        Outcomes in Chronic Myeloid Leukaemia

        Completed
        • Chronic Myeloid Leukaemia
          • York, United Kingdom
            Haematological Malignancy Research Network
          Jun 7, 2023

          Condition Vasoregulation Function Endothelium in CML Getting TKI

          Recruiting
          • Chronic Myeloid Leukaemia
          • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
          • Moscow, Russian Federation
          • +1 more
          Jan 11, 2023

          Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

          Not yet recruiting
          • Tyrosine Kinase Inhibitors
          • Chronic Myeloid Leukemia
          • treatment of TKI in CML
          • Poitiers, France
            Chu Poitiers
          Feb 21, 2023

          Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

          Recruiting
          • Myeloid Malignancies
          • +3 more
          • Houston, Texas
            M D Anderson Caner Center
          Nov 17, 2022

          CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

          Recruiting
          • CML, Chronic Phase
          • CML, Accelerated Phase
          • HS-10382(Part 1: Dose escalation)
          • HS-10382(Part 2: Dose expansion)
          • Wuhan, Hubei, China
            Union Hospital affiliated to Tongji Medical College of Huazhong
          Jan 12, 2023

          AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)

          Not yet recruiting
          • AML, Adult
          • Biological characterization of AML with MECOM or atypical 3q26 rearrangements
          • (no location specified)
          Apr 21, 2023